PAA 4.88% 21.5¢ pharmaust limited

Ann: DNDi contract extension for PharmAust subsidiary Epichem, page-15

  1. 1,034 Posts.
    lightbulb Created with Sketch. 179
    True but nothing lasts forever, just lucky I guess that Anusha “arrived” on our doorstep hired with a “plan to achieve Business Development, revenue and profit growth in line with both the Epichem Pty Ltd and the PharmAust Ltd strategic objectives.”
    Things haven’t looked this good for some years, and I haven’t felt more optimistic than I do now, yes there have been tough times but the LTHs have held the shit together, mostly anyway, how many other stocks are this tightly held, certainly some hard core MFs on the paa registry. Now is not the time to be sad about the road travelled with so much opportunity ahead, no guarantees in this caper. A bit of volatility would have been nice, lick of the ice cream so to speak, lucky we had covid hey, looking forward to what 2023 brings but plenty of life still in 2022 it seems, come on Santa give Bucky a smile for Christmas.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
21.5¢
Change
0.010(4.88%)
Mkt cap ! $85.12M
Open High Low Value Volume
21.5¢ 22.0¢ 21.5¢ $166.2K 772.5K

Buyers (Bids)

No. Vol. Price($)
1 6499 21.5¢
 

Sellers (Offers)

Price($) Vol. No.
22.0¢ 264679 3
View Market Depth
Last trade - 11.08am 24/06/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.